Identifying an Inciting Antigen Is Associated With Improved Survival in Patients With Chronic Hypersensitivity Pneumonitis
Evans R. Fernández Pérez(National Jewish Health), Kevin K. Brown(Health Protection Surveillance Centre), Amy L. Olson(National Jewish Health), Tristan J. Huie(National Jewish Health), Olga Tourin, Jeffrey J. Swigris(National Jewish Health), Anna Forssén(National Jewish Health), Joshua J. Solomon(National Jewish Health)
Cited by 394
Related Papers
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
|New England Journal of Medicine|2011|1.1k
Changes in Clinical and Physiologic Variables Predict Survival in Idiopathic Pulmonary Fibrosis
|American Journal of Respiratory and Critical Care Medicine|2003|762
A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis
|New England Journal of Medicine|2004|652